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Phialophora verrucosa is a dematiaceous fungus that causes mainly chromoblastomycosis,
but also disseminated infections such as phaeohyphomycosis and mycetoma. These
diseases are extremely hard to treat and often refractory to current antifungal therapies.
In this work, we have evaluated the effect of 1,10-phenanthroline-5,6-dione (phendione)
and its metal-based complexes, [Ag (phendione)2]ClO4 and [Cu(phendione)3](ClO4)2.4H2O,
against P. verrucosa, focusing on (i) conidial viability when combined with amphotericin
B (AmB); (ii) biofilm formation and disarticulation events; (iii) in vitro interaction with human
macrophages; and (iv) in vivo infection of Galleria mellonella larvae. The combination of
AmB with each of the test compounds promoted the additive inhibition of P. verrucosa
growth, as judged by the checkerboard assay. During the biofilm formation process over
polystyrene surface, sub-minimum inhibitory concentrations (MIC) of phendione and its
silver(I) and copper(II) complexes were able to reduce biomass and extracellular matrix
production. Moreover, a mature biofilm treated with high concentrations of the test
compounds diminished biofilm viability in a concentration-dependent manner. Pre-treatment
of conidial cells with the test compounds did not alter the percentage of infected THP-1
macrophages; however, [Ag(phendione)2]ClO4 caused a significant reduction in the number
of intracellular fungal cells compared to the untreated system. In addition, the killing
process was significantly enhanced by post-treatment of infected macrophages with the
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test compounds. P. verrucosa induced a typically cell density-dependent effect on G.
mellonella larvae death after 7 days of infection. Interestingly, exposure to the silver(I)
complex protected the larvae from P. verrucosa infection. Collectively, the results
corroborate the promising therapeutic potential of phendione-based drugs against fungal
infections, including those caused by P. verrucosa.
Keywords: 1,10-phenanthroline-5,6-dione, chromoblastomycosis, dematiaceous fungi, antifungal activity, cellular
interaction

INTRODUCTION

Cytotoxicity
assays
revealed
that
phendione,
[Ag(phendione)2]+, and [Cu(phendione)3]2+ were well tolerated
in vitro by several mammalian tumor and non-tumor lines
and also macrophages, and in vivo by Swiss mice and Galleria
mellonella larvae (McCann et al., 2012; Gandra et al., 2020).
This insect larva is a good and alternative in vivo experimental
model due to the similarities exhibited with respect to the
innate immune system of mammals, its ease of manipulation,
low cost, and ethical acceptance (Jemel et al., 2020). Thus,
G. mellonella larvae are widely used to assess the toxicity,
efficacy, and safety of conventional antifungal agents and potential
new drugs (Kavanagh and Sheehan, 2018; Maurer et al., 2019;
Treviño-Rangel et al., 2019; Jemel et al., 2020).
The antimicrobial efficacy of phendione and its metal-based
complexes has been shown against planktonic cells and also
biofilm-growing cells (Viganor et al., 2016; Gandra et al.,
2017; Ventura et al., 2020). Several studies have highlighted
the biofilm relevance in the fungal pathogenesis, contextualizing
the real issue of this structure formation in the medical settings
(Vila and Rozental, 2016; Santos et al., 2018; Wall et al.,
2019). This complex microbial community, which is adhered
to a surface, is surrounded by an extracellular matrix that
gives its cells several advantages, such as increased virulence,
immune system, and environmental stress protection as well
as resistance to antimicrobial agents (Costa-Orlandi et al.,
2017; Santos et al., 2018). The biofilm extracellular matrix is
formed mainly by polysaccharides, but also contains proteins,
lipids, and DNA. This matrix is one of the most relevant
structures of the biofilm and is directly associated with
antimicrobial resistance (Ramage et al., 2012; Santos et al.,
2018). In recent years, the capability of filamentous fungi
(e.g., Aspergillus fumigatus, Paracoccidioides brasiliensis,
Scedosporium spp., and Exophiala dermatitidis) to form a
biofilm has been well documented (Kaur and Singh, 2014;
Sardi et al., 2015; Mello et al., 2016; Kirchhoff et al., 2017).
The ability of P. verrucosa to establish a biofilm on a polystyrene
surface was previously investigated by our research group,
and it was found that biofilm-growing P. verrucosa cells were
more resistant to the action of conventional antifungal drugs
than their planktonic counterparts (unpublished data).
The present study was designed to investigate the effects
of phendione, [Ag(phendione)2]+, and [Cu(phendione)3]2+ on
P. verrucosa, focusing on (i) the combination of these test
agents with the classical antifungal drug, amphotericin B, (ii)
biofilm formation and disarticulation, (iii) the in vitro interaction
with human macrophages; and (iv) in vivo infection using
G. mellonella larvae as a model.

Phialophora verrucosa is a well-known chromoblastomycosis
etiological agent that may also cause other cutaneous and
subcutaneous diseases as well as disseminated infections, such
as phaeohyphomycosis and mycetoma (Turiansky et al., 1995;
Tong et al., 2013; Queiroz-Telles et al., 2017). P. verrucosa has
been observed in patients suffering with distinct illnesses,
including keratitis, endophthalmitis, sinusitis, osteomyelitis, and
endocarditis (Lundstrom et al., 1997; Hofmann et al., 2005;
Campos-Herrero et al., 2012). Infections caused by this melanized
filamentous fungus can affect both immunocompetent and
immunosuppressed individuals (Lundstrom et al., 1997; Qiu
et al., 2019). To date, there is no gold standard therapy for
these incapacitating and neglected diseases. Overall, the infections
caused by P. verrucosa tend to chronicity and hinder treatments,
leading to recurrence and resistance to available conventional
therapies (Li et al., 2014; Brito and Bittencourt, 2018). This
scenario has emphasized the necessity for the development of
new drugs against P. verrucosa infections, to be administered
either alone or in combination with established antifungal agents.
Metal-based drugs have attracted enormous attention due
to their pharmacological effects, which includes anticancer,
anti-inflammatory, antioxidant, and antimicrobial activities (Mjos
and Orvig, 2014; Anthony et al., 2020). In fact, inorganic
medicinal chemistry has advanced in recent years, providing
an alternative therapeutic approach to the purely organic
antimicrobial agents (Lemire et al., 2013; Viganor et al., 2017;
Claudel et al., 2020). Several studies have shown that
1,10-phenanthroline (phen) and its derivatives, as ligands
coordinated to transition metals, exhibit potent antifungal
activity against Candida albicans and non-albicans Candida
species, such as C. tropicalis, C. krusei, C. glabrata, and
C. haemulonii (Geraghty et al., 2000; McCann et al., 2000,
2012; Coyle et al., 2003; Hoffman et al., 2015; Gandra et al.,
2017, 2020). In a previous study, we showed that
1,10-phenanthroline-5,6-dione (phendione) and its silver(I) and
copper(II)
complexes,
[Ag(phendione)2]ClO4
and
[Cu(phendione)3](ClO4)2.4H2O (henceforth represented as their
biologically
active
cations
[Ag(phendione)2]+
and
2+
[Cu(phendione)3] ), affected crucial physiological events of P.
verrucosa (Granato et al., 2017). These three agents inhibited
fungal proliferation, presenting minimum inhibitory
concentration [MIC; mg/L (μM)] values of 2.5 (12.0), 2.5 (4.0),
and 5.0 (5.0), respectively. Moreover, the compounds affected
filamentation, sterol production, and the metallo-type peptidase
activity of P. verrucosa (Granato et al., 2017).
Frontiers in Microbiology | www.frontiersin.org
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MATERIALS AND METHODS

the broth microdilution assay in accordance with the document
M38-A2 CLSI (2008) and Mello et al. (2016). Firstly, the
compounds were examined for their ability to modulate biofilm
formation. Conidia (1 × 106 cells) were placed in flat-bottom
96-well polystyrene microtiter plates containing RPMI medium
supplemented or not with each test compound at concentrations
varying from MIC to ⅛ × MIC values. After 72 h, non-adhered
fungal cells were removed and the plates containing adhered
biofilm-growing cells were subjected to colorimetric assays
designed to measure the following biofilm parameters: biomass,
viability, and extracellular matrix. The biomass quantification
was evaluated after biofilm fixation with methanol (at 99%),
followed by staining for 20 min with 0.3% crystal violet
solution and the absorbance read at 590 nm. The determination
of metabolic activity was conducted in non-fixed biofilms
by the addition of 100 μl of a solution containing
2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)
carbonyl]-2H-tetrazolium hydroxide (XTT, 0.04 mg) and
menadione (0.0005 mg) into the plate wells, followed by
incubation in the dark at 37°C for 4 h, and finally an
absorbance reading at 490 nm. The assessment of the
extracellular matrix was carried out using non-fixed biofilms,
by staining with 0.1% safranin solution and the absorbance
read at 530 nm (Mello et al., 2016). In order to investigate
the effect of phendione and its metal complexes on mature
biofilms, P. verrucosa conidia (1 × 106 cells) were added to
96-well polystyrene microplates and incubated for 72 h. Then,
different concentrations of the test compounds, ranging from
MIC to 64 × MIC values, were added to the plates and
these were incubated for an additional 48 h. The biofilm
MIC90 value (bMIC90) was determined by considering the
lowest concentration of each test compound capable of causing
a 90% reduction in biofilm viability (Romera et al., 2019).
System controls were prepared with non-treated cells in RPMI
medium supplemented or not with DMSO, and RPMI medium
containing DMSO or not. All dyes and reagents used for
the colorimetric assays were obtained from Sigma-Aldrich.
The absorbance measurements were performed using a
microplate reader (SpectraMax M3, Molecular Devices,
United States). Biofilm formation was observed using an
inverted microscope (Nikon TS100-F, Tokyo, Japan) with a
×40 objective lens.

Fungal Growth Conditions

P. verrucosa (strain FMC.2214 isolated from a human patient
with chromoblastomycosis and used in our previous work;
Granato et al., 2017) was maintained in Sabouraud dextrose
agar (SDA) medium with mineral oil at 4°C. For all assays,
fungal cells were cultivated for 7 days under constant agitation
(130 rpm) at 26°C in 100 ml of Czapek-Dox broth medium
(BD-Difco, United States). Conidia were obtained by gauze
filtering followed by centrifugation at 4,000 × g for 10 min.
The fungal cells were then washed three times with saline
solution (0.85% NaCl), and the number of conidia cells was
estimated using a Neubauer chamber (Granato et al., 2015).

Test Compounds

Phendione was purchased from Sigma-Aldrich. [Ag(phendione)2]+
and [Cu(phendione)3]2+ were prepared by reacting phendione
with the appropriate metal perchlorate salts in accordance with
procedures previously published by McCann et al. (2004). For
all of the experiments, the compounds were dissolved in dimethyl
sulfoxide (DMSO; Sigma-Aldrich).

Combinatory Effects of Phendione and Its
Metal Complexes With Amphotericin B on
P. verrucosa Viability

The drug combinations were assessed using the checkerboard
microdilution method as described by Chudzik et al. (2019).
Briefly, initial concentrations equivalent to 8 × MIC of
amphotericin B (AmB, MIC = 6.25 mg/L) were serially diluted
in a cross fashion mode against 4 × MIC of each compound
(phendione, [Ag(phendione)2]+, and [Cu(phendione)3]2+) in
96-well plates containing Roswell Park Memorial Institute (RPMI)
1640 medium (Sigma-Aldrich). Thus, the final concentrations
range from 0.09 to 50 mg/L for AmB, 0.039 to 20 mg/L for
[Cu(phendione)3]2+, and 0.019 to 10 mg/L for both phendione
and [Ag(phendione)2]+. The inoculation and culture conditions
followed the Clinical and Laboratory Standards Institute (CLSI,
2008) standard document M38-A2 for filamentous fungi with
some minor modifications (Granato et al., 2017). Minimum
inhibitory concentration values were established when the
combination of AmB and each test compound inhibited 100%
of the fungal growth as evidenced by visual inspection and
the resazurin staining assay (Liu et al., 2007). The interaction
type of two-drug combination was defined according to the
fractional inhibitory concentration index (FICI) from the following
formula: FICI = FICA + FICB, where FICA and FICB = MIC
of drug A or B in combination divided by the MIC of drug
A or B alone. Synergism was established when FICI value ≤ 0.5;
additivity FICI > 0.5 to < 2.0; indifference FICI ≥ 2.0 to <4.0;
and antagonism FICI ≥ 4.0 (Chudzik et al., 2019).

Effects of Phendione and Its Metal
Complexes on P. verrucosa-Macrophage
Interaction
Cell Culture and Stimulation

Human monocytic leukemia THP-1 cells (ATCC TIB-202) were
cultured in 25 cm3 culture flasks containing RPMI 1640 medium
and 10% fetal bovine serum (Sigma-Aldrich) at 37°C in a 5%
CO2 atmosphere. For experimental assays, 1 × 106 cells were
added to each well of a 24-well cell culture plate and cultivated
in the same conditions as detailed above, with the addition
of phorbol myristate acetate (PMA, 80 nM, Sigma-Aldrich)
to promote the differentiation of monocytic cells into
macrophages. After 24 h, the THP-1 cells were washed three
times with RPMI and incubated in fresh medium without

Effects of Phendione and Its Metal
Complexes on P. verrucosa Biofilms

In this set of experiments, phendione, [Ag(phendione)2]+ and
[Cu(phendione)3]2+ were tested on P. verrucosa biofilm using
Frontiers in Microbiology | www.frontiersin.org
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Effect of [Ag(phendione)2]+ on
G. mellonella Larvae Infected With
P. verrucosa

PMA for an additional 24 h to allow for cell recovery. The
differentiation of THP-1 monocytes into macrophages was
confirmed by observing the cells adhesion capacity to culture
plates and alteration of their morphology to a flat, amoeboid,
and spreading shape using inverted microscope Nikon
(Batista-Silva et al., 2016).

G. mellonella Larvae

The larvae of G. mellonella were reared in the insectary of
the Department of Biochemistry of the Institute of Chemistry
at UFRJ in plastic boxes at 21°C in the dark. Healthy larvae
from the last instar with similar size (15–20 mm) and weight
(0.2 g), and without alterations in their color, were chosen
for the experiments. In order to determine the in vivo cytotoxicity
and the antifungal activity of each test compound, 10 larvae
were used in each experimental system (McCann et al., 2012;
Fernandes et al., 2017).

Fungi-Host Cells Interaction: Pre-treatment Assay

Conidia (2 × 106 cells) were treated with each test compound
at concentrations varying from ¼ × MIC to 2 × MIC values,
and after 20 h at 35°C, the fungal viability was assessed using
the XTT assay (Mowat et al., 2007). For the interaction assay, P.
verrucosa conidia were treated for 20 h with a non-cytotoxic
concentration of each test compound, washed, and incubated for
30 min with the fluorescent dye PKH26 (2 μM; Sigma-Aldrich).
After that, 250 μl of fetal bovine serum were added to interrupt
the reaction, and the conidial cells were then washed and
re-suspended in RPMI medium and incubated with macrophages
in a 10:1 ratio (fungi:macrophage) for 3 h in a 5% CO2 atmosphere
at 37°C. The interaction systems were washed three times with
sterile phosphate-buffered saline, pH 7.2 (PBS) and then with
2 mM PBS-EDTA buffer for their transference to cytometry tubes
(Ersland et al., 2010). The interaction was monitored by flow
cytometry (BD FACSAria) using Flowjo software. Results were
represented as percentage of infected macrophages, which indicates
the percentage of macrophage infected with fluorescent-labeled
conidial cells. Systems consisting of non-treated conidia (control)
and unlabeled conidia were also examined. The fluorescence values
were adjusted after subtracting the non-specific fluorescence values
of unlabeled cells (autofluorescence). In parallel, macrophages
infected with either untreated or treated conidial cells were lysed
with sterile cold water, and the suspensions were plated onto
SDA medium to count the number of colony forming units (CFU;
Palmeira et al., 2008).

Larval Survival Assay

Firstly, the non-toxic concentrations of [Ag(phendione)2]+ and
the appropriate fungal cellular density were determined as
described by McCann et al. (2012). Briefly, the compound
(10 μl) was administered by injection through the last left
proleg directly into the larvae haemocoel, using a Hamilton
syringe, resulting in the final concentrations of either 5 or
10 μg compound/larva. Simultaneously, P. verrucosa conidia
were suspended in PBS and adjusted to final densities equal
to 1 × 104, 1 × 105, 1 × 106, 4 × 106, or 1 × 107 and inoculated
as described above into each group of G. mellonella larvae.
Then, the larvae were incubated at 37°C for 7 days and survival
monitored every 24 h. Larvae mortality was assessed by lack
of movement in response to mechanical stimulus. Larvae
inoculated with 10 μl of PBS or DMSO were used as control
systems. Infected larvae images were obtained after 1 h of
incubation. For antifungal assessment, each G. mellonella larvae
group was infected with P. verrucosa conidia, at a concentration
presenting an intermediate rate of larvae mortality, and after
2 h a non-cytotoxic concentration of the test compound was
injected. After that, the experimental protocol and the survival
rate determination were performed as detailed above.

Fungi-Host Cells Interaction: Post-treatment
(Killing) Assay

In this set of experiments, the effect of the test compounds
on macrophage viability was initially investigated. THP-1
macrophages (1 × 106) were incubated in a 96-well cell culture
plate for 20 h in the absence (control) or in the presence of
each test compound at a concentration varying from 0.03 to
5 mg/L. Then, the viability of macrophages was assessed after
addition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT, Sigma-Aldrich) at 0.5 mg/ml and incubation
for 3 h at 37°C as described by Mosmann (1983). Subsequently,
in order to investigate the killing capability of THP-1 macrophages
against P. verrucosa, viable conidia were washed in PBS and
transferred to a 24-well plate containing macrophages at 10:1
ratio (fungi:macrophage) and incubated for 1 h at 37°C.
Non-adhered conidia were removed and the interaction systems
were incubated for 20 h with RPMI medium supplemented
or not (control) with a non-cytotoxic concentration of test
compound. The cultures were washed with PBS, lysed with
sterile cold water and the suspensions then plated onto SDA
medium for establishing the CFU number (Palmeira et al., 2008).

Frontiers in Microbiology | www.frontiersin.org

Statistical Analysis

The experiments were performed in triplicate in three
independent experimental sets. The graphics and data were
constructed and analyzed statistically by means of the ANOVAtest. Survival curves of G. mellonella larvae experiments were
constructed using the method of Kaplan-Meier and compared
using the Log-Rank (Mantel-Cox) test. All statistical analyses
were performed with GraphPad Prism 5.0 software. Values of
p = 0.05 or less were assumed as significant.

RESULTS AND DISCUSSION
Combinatory Effects of Phendione and Its
Metal Complexes With Amphotericin B on
P. verrucosa Viability

Using the checkerboard assay, we firstly investigated the effects
of AmB combined with each of the test compounds (Table 1).
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TABLE 1 | Effects of phendione and its metal complexes combined with amphotericin B on Phialophora verrucosa growth.
MIC mg/L (μM)
Agents
AmB
Phendione
AmB
[Ag(phendione)2]+
AmB
[Cu(phendione)3]2+

Alone

Combined

FIC

FICI

6.2 (6.8)
2.5 (12.0)
6.2 (6.8)
2.5 (4.0)
6.2 (6.8)
5.0 (5.0)

3.1 (3.4)
1.2 (6.0)
3.1 (3.4)
1.2 (2.0)
1.5 (3.4)
2.5 (2.5)

0.5
0.5
0.5
0.5
0.2
0.5

1.0
1.0
0.7

The type of interaction was determined by calculating the fractional inhibitory concentration (FIC) index (FICI) as described by Chudzik et al. (2019) and detailed in Material and
Methods. Minimum inhibitory concentration (MIC) was defined as the lowest concentration capable of inhibiting 100% of fungal growth. AmB, amphotericin B.

The
combinations,
AmB-[Cu(phendione)3]2+
and
AmB-[Ag(phendione)2]+, were both additive (FICI = 0.7 and
1.0, respectively). Although none of the drug combinations
displayed synergism (FICI ≤ 0.5) in the present case, such an
effect has been observed in previous studies involving
combinations of the metal-phendione complexes with classical
antifungal drugs. Eshwika et al. (2004) showed that C. albicans
treated with non-cytotoxic concentrations of [Ag(phendione)2]+
became more susceptible to miconazole and AmB. In a later
study on C. albicans, the combination of AmB with copper(II)
ions (AmB-Cu(II) complex) was again found to be more effective
than AmB alone (Gagoś et al., 2011; Chudzik et al., 2013). It
has been suggested that drug combinations with an additive
effect may enhance pharmaceutical efficacy and reduce toxicity
when each compound targets distinct stages of the same
biological pathway (Spitzer et al., 2017). Importantly, the
combination of benzothioureas with caspofungin has been
shown to function in an additive manner regarding anticryptococcal activity, even though caspofungin on its own is
ineffective against Cryptococcus species (Hartland et al., 2016;
Spitzer et al., 2017). Overall, metal-based drugs have different
modes of action conventional organic antifungal agents, thus
combination therapy could potentiate the effect as well as
possibly minimizing both resistance and toxicity.

The test compounds were also evaluated regarding their
ability to disturb a mature biofilm formed by P. verrucosa.
Phendione, [Ag(phendione)2]+, and [Cu(phendione)3]2+ inhibited
fungal viability by approximately 90% (bMIC90) when treated
with concentrations [mg/L (μM)] of 20 (96), 80 (128), and
20 (20), respectively (Figures 1D–F). Moreover, biofilm cells
were more resistant to the test compounds, since their bMIC90
values were higher than those observed for the planktonic
counterparts (Granato et al., 2017), increasing by about 4-,
8-, and 32-fold to [Cu(phendione)3]2+, phendione, and
[Ag(phendione)2]+, respectively. Previous studies had shown
that the biofilm of the C. haemulonii species complex was
also disturbed by phen- and phendione-containing compounds,
including copper(II) and silver(I) complexes (Gandra et al.,
2017). In contrast to P. verrucosa, silver(I) chelates (16 mg/L,
25.5 μM) had a lower geometric mean of the bMIC values
than their copper(II) counterparts (27.4 mg/L, 28.4 μM) for
the C. haemulonii species complex. However, in comparison
to the metal complexes containing perchlorate counter anions,
the most active were manganese(II), silver(I), and copper(II)
phen chelates containing coordinated dicarboxylate anions,
which presented bMIC50 values below 10 μM for these
opportunistic yeasts (Gandra et al., 2017).

Effects of Phendione and Its Metal
Complexes on the Interaction Between
P. verrucosa and Human Macrophages

Effects of Phendione and Its Metal
Complexes on P. verrucosa Biofilms

The effectiveness of the phendione-based drugs to inhibit
P. verrucosa conidial growth was previously described by
our
research
group,
with
the
following
order:
[Cu(phendione)3]2+ > [Ag(phendione)2]+ > phendione (Granato
et al., 2017). Herein, we evaluated the effects of the test compounds
upon biofilm formation by P. verrucosa on a polystyrene substrate.
The fungal cells (1 × 106) incubated with sub-MIC concentrations
preserved their metabolic viability along the process of biofilm
formation, as shown by the XTT assay (Figure 1A). However,
the biofilm biomass was affected by the incubation with the
test compounds, showing a significant reduction when treated
with phendione and [Cu(phendione)3]2+ at both ¼ × and
⅛ × MIC values, as well as with [Ag(phendione)2]+ at ½ × MIC
value (Figure 1B). The extracellular matrix production was also
affected by [Ag(phendione)2]+ at both ½ × and ¼ × MIC values,
and by phendione at ¼ × MIC (Figure 1C).

Frontiers in Microbiology | www.frontiersin.org

Firstly, P. verrucosa conidial (2 × 106) viability was assessed
after treatment with different concentrations of the test
compounds. The XTT assay showed that only the highest
concentration (2 × MIC) affected fungal viability after 20 h
(Figure 2A). The pre-treatment of P. verrucosa conidia with
the MIC value of each compound did not significantly affect
the percentage of infected macrophages (Figure 2B). However,
the number of intracellular viable conidia was significantly
diminished (around 60%) when the fungal cells were pre-treated
with [Ag(phendione)2]+, as judged by the CFU assay (Figure 2C).
In order to investigate the killing capability of macrophages
against P. verrucosa during the in vitro treatment, we firstly
evaluated the effect of the test compounds on macrophage
viability using the MTT assay. The results showed that phendione
and its silver(I) complex were less toxic than the copper(II)
complex, since around 90% of the macrophages remained viable
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FIGURE 1 | Effects of phendione and its metal complexes on P. verrucosa biofilm formation and maturation. Conidia (1 × 106) were added to 96-well plates
containing Roswell Park Memorial Institute (RPMI) medium supplemented with sub-MIC concentrations of each test compound. After incubation for 72 h at 37°C,
(A) cell viability, (B) quantification of biomass, and (C) extracellular matrix were evaluated, as described in Material and Methods. The same conidia density (D–F)
was placed to interact with polystyrene for 72 h in RPMI medium. Then, concentrations varying from MIC to 64 × MIC of each test compound were added and the
plates incubated for additional 48 h. The MIC90 values of the biofilm (bMIC90) were detected using the XTT reduction assay. Systems containing non-treated conidia
were also prepared (CTRL, control). The eluent (dimethyl sulfoxide, DMSO) did not affect fungal growth (data not shown). The symbol (*) highlights the MIC values
that caused a statistically significant reduction on each evaluated parameter in relation to the respective control (p < 0.05). Representative images of biomass (crystal
violet-stained) formed by P. verrucosa non-treated (CTRL, control) and treated with phendione (¼ × MIC) and its silver(I) (½ × MIC) and copper(II) (¼ × MIC)
complexes. Bar: 20 µm.

following treatment with 1.25 (6 μM), 1.25 (2 μM), and
0.31 mg/L (0.31 μM) concentrations, respectively (Figure 3A).
Similarly, previous cytotoxicity studies showed that animal cell
Frontiers in Microbiology | www.frontiersin.org

lineages were more tolerant toward [Ag(phendione)2]+.
McCann et al. (2012) showed that [Ag(phendione)2]+
(IC50 > 10 mg/L; 15.9 μM) was less toxic than [Cu(phendione)3]2+
6
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FIGURE 2 | Effects of phendione and its metal complexes on P. verrucosa-macrophage interaction. (A) Conidia (2 × 106) were treated for 20 h with each test
compound in order to establish non-cytotoxic concentrations using the XTT assay. Then, the fungal cells (B,C) were treated with the MIC values of each compound,
washed, and added to 24-well plates containing macrophages, in a 1:10 ratio (macrophage:fungi). After 3 h at 37°C, (B) the cells were transferred to tubes and
subjected to flow cytometry to determine the number of infected macrophages, (C) the cells were washed, lysed with sterile cold water and the colony forming units
(CFU) counted. Systems containing non-treated conidia were also prepared (CTRL, control). The eluent (DMSO) did not affect fungal growth (data not shown). For
the flow cytometry assay, conidia were stained with PKH26. The values represent the mean SD of three independent experiments performed in triplicate. Asterisks
indicate values of p ≤ 0.05.

(IC50 = 6.1 mg/L; 6.3 μM) when murine macrophages (RAW
264.7 lineage) were assayed. In addition, Gandra et al. (2017)
assessed the toxicity of the same compounds against A549, a
lung epithelial cell lineage, and showed that the CC50 value
was significantly larger for the silver(I) complex (3.76 mg/L)
than its copper(II) analogue (0.68 mg/L). Herein, we showed
that the infected macrophages, subsequently treated for 20 h
with non-toxic concentrations of phendione [1.25 mg/L (6 μM)],
[Ag(phendione)2]+ [1.25 mg/L (2 μM)], and [Cu(phendione)3]2+
Frontiers in Microbiology | www.frontiersin.org

[0.31 mg/L (0.31 μM)], were able to reduce the viability of
intracellular conidial cells by approximately 65, 60, and 70%,
respectively (Figure 3B).
The mechanism of action of metal complexes of phen and
phendione has not yet been fully established. However, the
impact of these compounds on fungal cells can be attributed
to their ability to induce different cellular changes, such as
disruption of the cell membrane, rupture of internal organelles,
nuclear fragmentation, sequestration of essential metals, and
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A

B

FIGURE 3 | Effects of phendione and its metal complexes on THP-1 viability and the ability of macrophages to kill P. verrucosa conidia. (A) Macrophages (1 × 106)
were incubated in the absence (CTRL, control) or in the presence of phendione and its silver(I) and copper(II) complexes (0.03–5 mg/L) for 20 h. After treatment,
macrophage viability was determined using the MTT assay. (B) THP-1 cells were infected with P. verrucosa conidia in a ratio of 1:10 (macrophage:fungi) for 1 h.
Then, non-adherent fungi were removed and the microplates incubated for an additional 20 h with non-cytotoxic concentrations [mg/L (μM)] of phendione [1.25 (6)],
[Ag(phendione)2]+ [1.25 (2)], and [Cu(phendione)3]2+ [0.31 (0.31)]. Then, macrophages were washed and lysed with sterile cold water, and the suspensions were
plated onto sabouraud dextrose agar (SDA) medium to count the number of colony forming units (CFU). The values represent the mean SD of three independent
experiments performed in triplicate. Asterisks indicate values of p ≤ 0.05.

damage of the mitochondrial function (Coyle et al., 2003;
McCann et al., 2012). In the previous study involving P. verrucosa
conidia, we revealed some potential mechanisms of action of
these test compounds (Granato et al., 2017). The phendione
metal complexes were able to affect the production of fungal
membrane ergosterol, thus possibly contributing to cell death.
In addition, the complexes also inhibited the metallopeptidase
activity of P. verrucosa conidia (Granato et al., 2017). Inhibition
of this enzyme can prevent the fungal cells ability to access
peptides and amino acids essential for their nutrition and
thus restricting cell growth. From the current study, it is
evident that addition of the test compounds improved the
antifungal action of macrophages. The increase of compoundtreated P. verrucosa susceptibility to macrophage killing could
be related to an increase in the production of reactive oxygen
species by these phagocytes since the respiratory burst is one
of the most important mechanisms for the antimicrobial
immunity of phagocytic cells (Herb and Schramm, 2021).
Thus, the enhanced ability of macrophages to combat the
fungal infection could be explained by the direct action of
the test compounds on the intracellular conidia, and by the
induction of intracellular macrophage mechanisms that mediate

Frontiers in Microbiology | www.frontiersin.org

the antimicrobial immune responses, just as has previously
been reported in regard to the anti-mycobacterial and
antitumoral activities of phen- and phendione-based complexes
(Kellett et al., 2011; McCarron et al., 2018). However, further
studies are required in order to more fully understand the
mechanisms involved in the anti- P. verrucosa activity of the
test compounds.

Effects of [Ag(Phendione)2]+ on
G. mellonella Infected With P. verrucosa

Although the copper(II) chelate was the most effective in
disturbing a P. verrucosa mature biofilm, the silver(I) complex
was less toxic toward THP-1 and it also affected the viability
of conidial cells, at both pre- and post-treated proposals, in
the in vitro interactions with macrophages. Thus,
[Ag(phendione)2]+ was selected for the in vivo G. mellonella
experiments. At dosages of 5 and 10 μg per larva, the silver(I)
complex did not affect G. mellonella viability for a test period
of up to 7 days (Figure 4A). This result corroborated the
data obtained previously by McCann et al. (2012), who showed
the low toxicity of phendione and its metal complexes for
an exposure period of 72 h using the G. mellonella larvae as
8

April 2021 | Volume 12 | Article 641258

Granato et al.

Metallodrugs Action on P. verrucosa

an experimental model. Similarly, the test compounds were
also well tolerated by Swiss mice, as previously reported by
McCann et al. (2012). In that study, phendione,
[Ag(phendione)2]+, and [Cu(phendione)3]2+, at dosages up to
45 mg/kg, were injected into mice and after 7 days no deaths
were recorded. Interestingly, only [Ag(phendione)2]+,
administered at a concentration of 150 mg/kg over the same
time period, did not cause mortality, indicating that this
complex was the least toxic. Thus, mice tolerance was in the
order [Ag(phendione)2]+ > phendione > [Cu(phendione)3]2+
(McCann et al., 2012).
The survival of G. mellonella larvae following infection with
P. verrucosa was also studied (Figure 4A). After inoculation of

larvae with the lowest fungal densities (1 × 104 and 1 × 105),
80% survived up to the last day of monitoring. However,
1 × 106 conidia induced larvae death gradually until the fifth
day, and at the end of the incubation period only 30% survived.
Administering a cell density of 4 × 106 conidia caused a
reduction of 50% of viable larvae by the third day and 100%
mortality by the fifth day. In addition, it was found that
injection of 1 × 107 conidia triggered 80% of larval death by
the second day and 100% by the fourth day (Figure 4A).
These experiments demonstrated that the mortality of
G. mellonella infected with P. verrucosa was dependent upon
the fungal inoculum density. It is well known that disease
outcomes are influenced by the quantity of the infective particles.

A

B

C

FIGURE 4 | Effects of [Ag(phendione)2]+ on P. verrucosa infection of G. mellonella larvae. (A) Different cell densities of P. verrucosa conidia and [Ag(phendione)2]+, at
concentrations of 5 and 10 μg/larva, were injected in G. mellonella larvae and the survival rate determined over a total period of 7 days. (B) Representative images of
G. mellonella larvae 1 h post injection with (a) PBS/DMSO and different densities of P. verrucosa conidia (b) 1 × 104, (c) 1 × 105, (d) 1 × 106, (e) 4 × 106, and (f)
1 × 107. (C) Each larva was infected with P. verrucosa conidia (4 × 106), and after a period of 2 h was treated with the silver(I) complex at a concentration of either 5
or 10 μg/larva. Injection with only the PBS/DMSO eluent represents the control. The survival rate (10 larvae/systems) was monitored over 7 days, and death was
assessed by the lack of larval movement in response to a stimulus.

Frontiers in Microbiology | www.frontiersin.org

9

April 2021 | Volume 12 | Article 641258

Granato et al.

Metallodrugs Action on P. verrucosa

However, tests using the same invertebrate model infected
with Paracoccidioides lutzii and Histoplasma capsulatum revealed
that these fungi were lethal to the larvae and without any
correlation with cellular density (Thomaz et al., 2013). With
the current infection assay using P. verrucosa, it was observed
that the melanization of the larvae increased in accordance
with dispensed cell density. In fact, larvae inoculated with
the highest P. verrucosa cell density (1 × 107) immediately
became melanized, whereas with cell densities of 1 × 106 and
4 × 106, the pigmentation was observed only after 1 h
(Figure 4B). Larvae melanization, when exposed to other
fungi, has been well documented (Li et al., 2013; Thomaz
et al., 2013; Gandra et al., 2020). Like P. verrucosa, other
non-albicans Candida species induced early larvae melanization
and its progression was dependent upon inoculum density
(Silva et al., 2018). However, premature larvae melanization
was not observed following infection with Cryptococcus
neoformans (Trevijano-Contador et al., 2015). The G. mellonella
model was also used for studying the virulence of other fungi
that cause chromoblastomycosis and phaeohyphomycosis, such
as Fonsecaea spp. and Exophiala jeanselmei (Vicente et al.,
2017; Huang et al., 2018). Huang et al. (2018) showed that
the increase in fungal inoculum resulted in greater larval
mortality. In contrast to P. verrucosa, the authors observed
that F. monophora (1 × 106 conidia/larva) infection induced
G. mellonella melanization only on the second day post injection.
G. mellonella larvae melanization process occurs in response
to trauma or microbial cell invasion through the activation
of phenoloxidase (Trevijano-Contador and Zaragoza, 2019).
The insect enzymatic system can be activated during the
immune response after recognition of specific components,
such as β-glucans in the fungal cell wall (Pereira et al., 2018;
Trevijano-Contador and Zaragoza, 2019).
Addition of [Ag(phendione)2]+ at two non-toxic
concentrations (5 and 10 μg/larva) to G. mellonella larvae
which were pre-infected with P. verrucosa (inoculum density
of 4 × 106 conidia), resulted in an intermediate rate of larval
mortality. The results showed that by the third day of incubation,
50% of untreated larvae had perished, while 90% of larvae
treated with the same two concentrations of the silver(I)
complex remained alive (Figure 4C). On the fifth day, 100%
mortality was recorded for the untreated larvae. However,
80% of larvae survived after [Ag(phendione)2]+ treatment at
10 μg per larva. At the lower concentration of added
[Ag(phendione)2]+ (5 μg per larva) there was a 60% survival
rate, suggesting a dose-dependent effect. It was also found
that, following treatment with [Ag(phendione)2]+, 50% of larvae
survived until the last day of monitoring (Figure 4C), thus
clearly demonstrating a protective effect by the silver(I) complex.
In their study of G. mellonella infected with Candida spp.,
Rowan et al. (2009) found that the larvae survival rate was
increased after treatment with the silver(I) complex, [Ag2(mal)
(phen)3] (mal H2 = malonic acid). Gandra et al. (2020) showed
that different phen and phendione metal complexes, including
[Ag(phendione)2]+, were able to inhibit C. haemulonii
proliferation in G. mellonella infected larvae. In that
study, the manganese(II) phen chelate containing the
Frontiers in Microbiology | www.frontiersin.org

3,6,9-trioxaundecanedioate dianion was the most effective. The
antifungal efficacy against other fungi, such as Candida spp.,
Cryptococcus spp., Aspergillus spp., and Trichosporon spp. has
also been assessed using the G. mellonella model (Kavanagh
and Sheehan, 2018; Jemel et al., 2020). Thus, our present
work has demonstrated that the G. mellonella in vivo model
can be employed successfully to evaluate the antifungal
effectiveness of phendione complexes presenting in vitro
anti-P. verrucosa activity.

CONCLUSION
The silver(I) phendione complex, [Ag(phendione)2]+, is capable
of reducing the viability of P. verrucosa conidia following
interaction with human macrophages in vitro, and also conferring
protection, in vivo, to G. mellonella larvae infected with the
fungus. Transition metal complexes represent a novel group
of antifungal agents due to their multi-modal activity, low
cost, ease of synthesis, and their relatively high tolerance in
in vitro animal cells as well as in lower mammals and insects
used routinely as in vivo experimental models. Further studies
are ongoing in an effort to understand the mechanisms of
action of these metal complexes against P. verrucosa and
other fungi that also cause chromoblastomycosis and
phaeohyphomycosis. This advancement will further inform and
facilitate the development of more effective compounds with
reduced toxicity and enhanced potency against the microbes
responsible for these debilitating diseases.
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